Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses

Journal of Gene Medicine

Volumn 7, Issue 9, 2005, Pages 1246-1254

  Grønevik, Eirik ^a   Mathiesen, Iacob ^b   Lømo, Terje ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Inovio AS   (Norway)

Author keywords

DNA vaccination; Electroporation; Gene therapy; Inducible gene expression; Intramuscular injection; Transfection

Indexed keywords

DNA VACCINE; DOXYCYCLINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA VECTOR; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; QUADRICEPS FEMORIS MUSCLE; SPLEEN CELL; TH1 CELL; VACCINATION;

ANIMALS; CATTLE; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE THERAPY; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-4; LUCIFERASES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLASMIDS; SPLEEN; TH1 CELLS; TRANSFECTION; VACCINES, DNA;

EID: 25144498009     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.760     Document Type: Article

References (24)

1. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
2. Gronevik E, Tollefsen S, Sikkeland LI, et al. DNA transfection of mononuclear cells in muscle tissue. J Gene Med 2003; 5: 909-917.
3. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999; 6: 508-514.
4. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999; 96: 4262-4267.
5. Bachy M, Boudet F, Bureau M, et al. Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse. Vaccine 2001; 19: 1688-1693.
6. Selby M, Goldbeck C, Pertile T, et al. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 2000; 83: 147-152.
7. Tollefsen S, Tjelle T, Schneider J, et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 2002; 20: 3370.
8. Widera G, Austin M, Rabussay D, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000; 164: 4635-4640.
9. Durieux AC, Bonnefoy R, Busso T, et al. In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 2004; 6: 809-816.
10. Babiuk S, Baca-Estrada ME, Foldvari M, et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 2004; 110: 1-10.
11. Gronevik E, Vult von Steyern F, Kalhovde JM, et al. Gene expression and immune response kinetics using electroporation mediated DNA delivery to muscle. J Gene Med 2005; 7: 218-227.
12. Hartikka J, Sukhu L, Buchner C, et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001; 4: 407-415.
13. Shedlock DJ, Weiner DB. DNA vaccination: antigen presentation and the induction of immunity. J Leukoc Biol 2000; 68: 793-806.
14. Dalpke A, Zimmermann S, Heeg K. Immunopharmacology of CpG DNA. Biol Chem 2002; 383: 1491-1500.
15. Zelenay S, Elias F, Flo J. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Eur J Immunol 2003; 33: 1382-1392.
16. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
17. Lozes E, Huygen K, Content J, et al. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 1997; 15: 830-833.
18. Takeshita S, Takeshita F, Haddad DE, et al. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol 2000; 206: 101-106.
19. Lipford GB, Bauer M, Blank C, et al. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 1997; 27: 2340-2344.
20. Klinman DM, Yi AK, Beaucage SL, et al. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 1996; 93: 2879-2883.
21. Bureau MF, Naimi S, Torero IR, et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004; 1676: 138-148.
22. Snapper CM, Paul WE. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236: 944-947.
23. Kwissa M, Unsinger J, Schirmbeck R, et al. Polyvalent DNA vaccines with bidirectional promoters. J Mol Med 2000; 78: 495-506.
24. Perez N, Plence P, Millet V, et al. Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum. Gene Ther. 2002; 13: 2161-2172.